research

Merck (NYSE:MRK) announced that company researchers will participate in two new collaborative efforts led by the prominent academic institutions of the University of North Carolina Chapel Hill and the University of California San

Osiris posted net income of $4.4 million, or 13 cents per share, from a year ago profit of $15.7 million, or 48 cents per share. Analysts expected a profit of 9 cents per share.

Osiris is currently developing a product called Prochymal, which is composed of stem cells taken from adult bone marrow, and is seeking regulatory approval for the product.

Osiris Therapeutics (OSIR) is down 2.33% to $6.70 on a 72% drop in Q4 net income compared with last year, but earnings still topped the mean analyst estimate.

Northrop Grumman has been awarded a contract for cyberspace operations supporting the U.S. Navy's Space and Naval Warfare Systems Center Pacific (SSC Pacific) to provide cyberspace science, research, engineering and technology int

Gilead Sciences (GILD) today announced that it has acquired Calistoga Pharmaceuticals, a privately held company, for $375 million. GILD stated that with the acquisition, it hopes to expand its research capabilities into cancer dru

According to the company, it will respect the decision of the SBA although it is disappointed with the ruling.

SIGA Technologies (SIGA) says the Small Business Administration (SBA) Office of Hearings and Appeals affirmed the ruling of the SBA Area Office regarding SIGA's submission in response to a Request for Proposal from the Biomedical

The bank sees 2011 EPS of $0.77, down from $0.86 per share, and 2012 EPS of $1.28, up from $1.12 per share.

OpenTable is currently above its 50-day moving average (MA) of $75.14 and above its 200-day of $57.89.

Morgan Stanley adjusted its 2011 and 2012 EPS estimates for OpenTable (NASDAQ:OPEN) and maintained its equal-weight rating.

Polo Ralph Lauren (RL) posted net income of $168 million, or $1.72 per diluted share, for the third quarter of fiscal 2011, versus net income of $111 million, or $1.10 per diluted share, for the same period in fiscal 2010. The Str

The company posted record revenue of $33.8 million for the fourth quarter ended Dec. 31, a 29% increase over the $26.2 million reported for the same period in 2009. Net income was $4.3 million for the fourth quarter, or $0.20 per

Shares of Stratasys (SSYS) are up $4.80 to $40.18, or 11.61%, after the company reported strong fourth quarter and full year financial results that surpassed market expectations.

Morgan Stanley lowered its 2011 and 2012 EPS estimates for DuPont (NYSE:DD) and maintained its equal-weight rating and $56 price target. The bank sees 2011 EPS of $3.65, down from $3.71 per share, and 2012 EPS of $4.03, down from